Medium-term Business Plan “Vision 110 -Stage 2-”

Outline of Vision 110 -Stage 2-

Overview of Medium-Term Management Plan: "Vision 110 -Stage 2-

"Under the theme "Aggressive Investment for Sustainable Growth," we have positioned the acquisition of in-licensed products and assets—the engines of our mid-to-long-term growth—as our highest priority.

We are committed to this objective with unwavering conviction.Furthermore, by vigorously executing the business strategies outlined below, we aim to achieve our target outcomes and enhance the support and recognition we receive from all our stakeholders.

Vision 110 -Stage2-

  1. 1Expanding our development pipeline through proactive in-licensing investment
  2. 2Strengthening our capability to create high-value new drugs that meet medical needs
  3. 3Maximizing the uptake of new drugs
  4. 4Promoting health-related businesses that create synergies with our innovative drug business
  5. 5Building a sustainable corporate foundation

Positioning of the Medium-Term Management Plan "Vision 110 -Stage 2-" and Its Five Core Business Strategies

Image: Positioning of the Medium-Term Management Plan Vision 110 -Stage 2- and Its Five Core Business Strategies